Cargando…
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. NAFLD is considerably more frequent in patients with type 2 diabetes mellitus (T2DM) than in the general population and is also more severe histologically in this group. Sodium-glucose co-transpo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676552/ https://www.ncbi.nlm.nih.gov/pubmed/31391764 http://dx.doi.org/10.3748/wjg.v25.i28.3664 |